B-Bridge Trademark Details
Word Mark | B-Bridge |
---|---|
Status | Dead Registered 710 — Cancelled - Section 8 |
Current Owner
B-Bridge International, Inc. of Mountain View, CA
View all trademarks for B-Bridge International, Inc.Serial Number | 76664863 |
---|---|
Registration Number | 3486764 |
Status Date | Friday, March 20, 2015 |
Filing Date | Friday, March 20, 2015 |
Registration Date | Tuesday, August 19, 2008 |
Attorney | Maryam Imam |
Correspondent
Maryam Imam
LAW OFFICES OF IMAM
Suite 1010
111 N. Market Street
San Jose CA 95113
LAW OFFICES OF IMAM
Suite 1010
111 N. Market Street
San Jose CA 95113
Case File Statements
Goods & Services | Biosciences research products, namely, biochemical mechanisms used for research in the nature of transfection products, namely, quickstep transfection kit comprised of transfection reagents, for research purposes; Polymerase Chain Reaction (PCR) products, enzymes and reagents, namely, Taq deoxyribonucleic acid (DNA) Polymerase, Hot Start DNA Polymerase, deoxynucleotide triphosphate (dNTP) solutions, namely, sets of all four dNTPs 2'-Deoxyadenosine 5'-Triphosphate (dATP), 2'-Deoxycytidine 5'-Triphosphate (dCTP), 2'-Deoxyguanosine 5'-Triphosphate (dGTP), and 2'-Deoxythymidine 5'-Triphosphate (dTTP)), and Real Time PCR Kits comprised of chemicals, namely, DNA polymerase, Globin mixture containing glycerol, potassium chloride (KCl), dATP, dCTP, dGTP, dTTP and primers, magnesium chloride (MgCl2), reagents, and blood for research purposes; nucleic acid purification products, namely, plasmid DNA isolation kits comprised of chemicals, namely, transfection reagents for research purposes, ribonucleic acid (RNA) purification kits comprised of chemicals, namely, transfection reagents for research purposes, and high throughput purification kits comprised of chemicals, namely, buffers and buffers for lysis, binding, wash and elute, and mannitol-adenine-phosphate (MAP) solution containing mannitol, adenine and crystalline sodium dihydrogen phosphate for research purposes; apoptosis detection kits comprised of reagents for research purposes and chemicals consisting of buffers, fixatives, and biochemical stains; diabetes and obesity research products, namely, chemicals in the nature of human and mouse/rat adiponectin, resistin, leptin, and leptin-receptor enzyme-linked immunosorbent assay (ELISA) kits comprised of chemicals and anti-human leptin-receptor, wash buffer, recombinant human leptin-receptor, assay diluent, biotinylated anti-human leptin-receptor, concentrated horseradish peroxidase (HRP)-conjugated streptavidin, tetramethylbenzidine (TMB), and sulfuric acid substances for research purposes, and human endogenous secreted receptor for advanced glycation end products (esRAGE); ELISA kit comprised of chemicals in the nature of sulfuric acid, plate with absorbed anti-RAGE antibody, esRAGE intibody-horseradish peroxidase conjugated as Detection Antibody, 3,3', 5, 5'-tetramethylbenzidine and hydrogen peroxide, phosphate buffered saline containing bovine serum albumin, human esRAGE, phosphate buffered saline with Tween 20, for research purposes; interfering ribonucleic acid (RNAi) products, namely, small interfering RNA (siRNA) reagents for scientific research purpose, and GeneNet siRNA libraries and sequences in the nature of polymers for screening genome-wide for genes regulating cellular responses or signaling pathways, identifying potential drug targets or diagnostic markers that inhibit, enhance, or activate a selectable phenotype and finding crucial regulatory genes using routine growth selections or flow sorting; cell culture products, namely, chemicals in the nature of visceral adipocytes, epididymal adipocytes, subcutaneous adipocytes, and osteoclasts; chemicals for use in scientific research preparations, namely, full open reading frame (ORF) clones, full-length clones, sequence verified clones, and genomic clones for applications in protein expression, functional genomics, and functional analysis |
---|---|
Goods & Services | Biological research, consulting, and analytical services, provided by scientists, in the nature of analysis of chemicals and biological sequences, sample analysis, ribonucleic acid (RNA) design in the nature of polymer design, small interfering ribonucleic acid (siRNA) design, siRNA synthesis in the nature of synthesis of polymers for scientific research, biological research of cells, cell strain, biochemical mechanisms, antibodies and proteins, apoptosis detection, cell culture, clones, food, and nucleic acid purification; providing of chemical laboratory facilities |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, March 20, 2015 |
First Use Anywhere | Thursday, November 2, 2000 |
First Use In Commerce | Thursday, January 3, 2002 |
Primary Code | 001 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, March 20, 2015 |
First Use Anywhere | Thursday, November 2, 2000 |
First Use In Commerce | Thursday, January 3, 2002 |
Primary Code | 042 |
Trademark Timeline
-
Nov 02 2000First use anywhere for the mark
-
Nov 02 2000First use anywhere for the mark
-
Jan 03 2002First use in commerce for the mark
-
Jan 03 2002First use in commerce for the mark
-
Aug 21 2006Trademark application filed with USPTO
-
Aug 25 2006New Application Entered In Tram
-
Aug 29 2006Application Filing Receipt Mailed
-
Jan 16 2007Assigned To Examiner
-
Jan 26 2007Examiner's Amendment/priority Action Mailed
-
Jan 26 2007Examiners Amendment And/or Priority Action - Completed
-
Jan 29 2007Combined Examiner's Amendment/priority Action Entered
-
Mar 26 2007Correspondence Received In Law Office
-
Mar 26 2007Teas Response To Office Action Received
-
Mar 27 2007Teas/email Correspondence Entered
-
Apr 22 2007Non-Final Action Written
-
Apr 23 2007Non-Final Action Mailed
-
Jul 19 2007Paper Received
-
Aug 02 2007Amendment From Applicant Entered
-
Aug 02 2007Correspondence Received In Law Office
-
Aug 02 2007Assigned To Lie
-
Aug 27 2007Final Refusal Mailed
-
Aug 27 2007Final Refusal Written
-
Sep 07 2007Paper Received
-
Sep 11 2007Amendment From Applicant Entered
-
Sep 11 2007Correspondence Received In Law Office
-
Oct 11 2007Examiner's Amendment Entered
-
Oct 11 2007Examiners Amendment -Written
-
Oct 12 2007Examiners Amendment Mailed
-
Oct 15 2007Approved For Pub - Principal Register
-
Oct 16 2007Law Office Publication Review Completed
-
Oct 29 2007Withdrawn From Pub - Og Review Query
-
Nov 01 2007Previous Allowance Count Withdrawn
-
Jan 16 2008Withdrawal of Attorney Granted
-
Jan 16 2008Teas Withdrawal of Attorney Received
-
Jan 31 2008Assigned To Examiner
-
Feb 22 2008Non-Final Action Written
-
Feb 25 2008Non-Final Action Mailed
-
Mar 14 2008Attorney Revoked And/or Appointed
-
Mar 14 2008Teas Revoke/appoint Attorney Received
-
Apr 30 2008Law Office Publication Review Completed
-
Apr 30 2008Approved For Pub - Principal Register
-
Apr 30 2008Examiner's Amendment Entered
-
Apr 30 2008Notification of Examiners Amendment E-Mailed
-
Apr 30 2008Examiners Amendment E-Mailed
-
Apr 30 2008Examiners Amendment -Written
-
May 14 2008Notice of Publication
-
Jun 03 2008Published For Opposition
-
Aug 19 2008Registered-Principal Register
-
Aug 19 2008Trademark officially registered with the USPTO
-
Mar 20 2015Cancelled Sec. 8 (6-Yr)